Influence ofLeishmania (Viannia)Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis | Zendy

Jorge Arévalo | Zendy; Luis Ramirez | Zendy; Vanessa Adaui | Zendy; Mirko Zimic | Zendy; Gianfranco Tulliano | Zendy; César MirandaVerástegui | Zendy; Marcela Lazo | Zendy; Raúl LoayzaMuro | Zendy; Simonne De Doncker | Zendy; Anne Maurer | Zendy; François Chappuis | Zendy; JeanClaude Dujardin | Zendy; Alejandro LlanosCuentas | Zendy

Open Access

Influence ofLeishmania (Viannia)Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis

Author(s) -

Jorge Arévalo,

Luis Ramirez,

Vanessa Adaui,

Mirko Zimic,

Gianfranco Tulliano,

César MirandaVerástegui,

Marcela Lazo,

Raúl LoayzaMuro,

Simonne De Doncker,

Anne Maurer,

François Chappuis,

JeanClaude Dujardin,

Alejandro LlanosCuentas

Publication year - 2007

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/518041

Subject(s) - leishmaniasis , leishmania braziliensis , leishmania , biology , odds ratio , cutaneous leishmaniasis , parasite hosting , chemotherapy , medicine , microbiology and biotechnology , veterinary medicine , immunology , world wide web , computer science

Pentavalent antimonials (SbV) are the first-line chemotherapy for American tegumentary leishmaniasis (ATL). There are, however, reports of the occurrence of treatment failure with these drugs. Few studies in Latin America have compared the response to SbV treatment in ATL caused by different Leishmania species.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research